Skip to Main Content
Skip Nav Destination

Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms

Acta Haematol (2021) 144 (1): 48–57.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Sylvie Hermouet
Frontiers in Oncology (2023) 13
  • Dahniel Sastow
  • John Mascarenhas
  • Douglas Tremblay
Clinical Lymphoma Myeloma and Leukemia (2022) 22 (7): e507.
  • Jacinta Perram
  • David M. Ross
  • Donal McLornan
  • Krisstina Gowin
  • Nicolas Kröger
  • Vikas Gupta
  • Clinton Lewis
  • Nico Gagelmann
  • Nada Hamad
American Journal of Hematology (2022) 97 (11): 1464.
  • Paul Chauvet
  • Olivier Nibourel
  • Celine Berthon
  • Laure Goursaud
  • Benjamin Carpentier
  • Pauline Lionne-Huyghe
  • Mathieu Wemeau
  • Bruno Quesnel
Leukemia Research (2022) 118: 106871.
  • Franco Castillo Tokumori
  • Najla Al Ali
  • Onyee Chan
  • David Sallman
  • Seongseok Yun
  • Kendra Sweet
  • Eric Padron
  • Jeffrey Lancet
  • Rami Komrokji
  • Andrew T. Kuykendall
Clinical Lymphoma Myeloma and Leukemia (2022) 22 (7): e521.
  • Antoine N. Saliba
  • Naseema Gangat
Best Practice & Research Clinical Haematology (2022) 35 (2): 101379.
  • Chandan Saha
  • Luke Attwell
  • Claire N. Harrison
  • Donal P. McLornan
Blood Reviews (2022) 55: 100947.
  • Omar A. Shahin
  • Helen T. Chifotides
  • Prithviraj Bose
  • Lucia Masarova
  • Srdan Verstovsek
Acta Haematologica (2021) 144 (5): 484.
  • Olatoyosi Odenike
Clinical Lymphoma Myeloma and Leukemia (2021) 21: S127.
Close Modal

or Create an Account

Close Modal
Close Modal